ImageneBio, Inc.
IKNANASDAQ·US · USD
$6.02
+0.08 (+1.35%)
Close · 2026-06-26Price
Key statistics
Valuation
Market cap290.51M USD
Enterprise value-20.96M USD
Trailing P/E-0.50
Forward P/E-20.19
PEG ratio0.01
Price / sales0.00
Price / book0.60
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-18.32%
Return on equity-23.76%
Income (TTM)
Revenue0.00 USD
Gross profit-29.89M USD
EBITDA-41.22M USD
Net income-30.74M USD
Diluted EPS-$7.68
Rev. growth (YoY)0.00%
Balance sheet
Total cash95.64M USD
Total debt5.68M USD
Debt / equity4.90
Current ratio13.52
Book value / share$28.82
Cash flow (TTM)
Operating cash flow-29.18M USD
Levered free cash flow-22.73M USD
Shares & price
Shares outstanding48.26M
Float6.11M
Held by institutions76.21%
Beta0.50
50-day MA$15.75
200-day MA$17.08
52-week high$18.00
52-week low$3.94
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Earnings (EPS)
DateEst.ActualSurprise2025-09-090.330.33+0.00%2025-07-24-1.44-0.61+57.64%